Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Increased prevalence of esophageal squamous cell papilloma in eosinophilic esophagitis: incidental finding or disease related consequence?
Journal: Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus
Published: November 27, 2024
Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial.
Journal: Nature medicine
Published: January 08, 2024
MyPathway Human Epidermal Growth Factor Receptor 2 Basket Study: Pertuzumab + Trastuzumab Treatment of a Tissue-Agnostic Cohort of Patients With Human Epidermal Growth Factor Receptor 2-Altered Advanced Solid Tumors.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 04, 2023
Profiling the heterogeneity of colorectal cancer consensus molecular subtypes using spatial transcriptomics.
Journal: NPJ precision oncology
Published: February 24, 2023
Standardized Processing for Formalin-Fixed, Paraffin-Embedded Cell Pellet Immunohistochemistry Controls.
Journal: Journal of visualized experiments : JoVE
Published: August 15, 2022
T cell-dependent bispecific antibodies alter organ-specific endothelial cell-T cell interaction.
Journal: EMBO reports
Published: June 02, 2022
Indication-specific tumor evolution and its impact on neoantigen targeting and biomarkers for individualized cancer immunotherapies.
Journal: Journal for immunotherapy of cancer
Published: August 15, 2021
Origins and Timing of Emerging Lesions in Advanced Renal Cell Carcinoma.
Journal: Molecular cancer research : MCR
Published: July 20, 2021
Novel Anti-LY6G6D/CD3 T-Cell-Dependent Bispecific Antibody for the Treatment of Colorectal Cancer.
Journal: Molecular cancer therapeutics
Published: July 08, 2021
Automated Dissection Protocol for Tumor Enrichment in Low Tumor Content Tissues.
Journal: Journal of visualized experiments : JoVE
Published: April 12, 2021
Anti-LYPD1/CD3 T-Cell-Dependent Bispecific Antibody for the Treatment of Ovarian Cancer.
Journal: Molecular cancer therapeutics
Published: June 16, 2020
Last Updated: 09/26/2026